Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress SignalsKeisuke Fukuchi(Nagoya University), Toshinori Agatsuma(Daiichi Sankyo (Germany))Journal of OncologyNovember 4, 202210.1155/2022/3552793Cited by 7SaveCiteExport RISWatch citationsRelated PapersBystander killing effect of <scp>DS</scp>‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity|Cancer Science|2016|691Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models|Molecular Cancer Therapeutics|2024|29